These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11801698)

  • 1. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.
    Herholz K; Schopphoff H; Schmidt M; Mielke R; Eschner W; Scheidhauer K; Schicha H; Heiss WD; Ebmeier K
    J Nucl Med; 2002 Jan; 43(1):21-6. PubMed ID: 11801698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
    J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
    Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
    Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.
    Messa C; Perani D; Lucignani G; Zenorini A; Zito F; Rizzo G; Grassi F; Del Sole A; Franceschi M; Gilardi MC
    J Nucl Med; 1994 Feb; 35(2):210-6. PubMed ID: 8294987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.
    Soonawala D; Amin T; Ebmeier KP; Steele JD; Dougall NJ; Best J; Migneco O; Nobili F; Scheidhauer K
    Neuroimage; 2002 Nov; 17(3):1193-202. PubMed ID: 12414259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
    Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc-99m ethyl cysteinate dimer SPECT and 2-[F-18]fluoro-2-deoxy-D-glucose PET in Alzheimer's disease. Comparison of perfusion and metabolic patterns.
    Ishii K; Sasaki M; Sakamoto S; Yamaji S; Kitagaki H; Mori E
    Clin Nucl Med; 1999 Aug; 24(8):572-5. PubMed ID: 10439176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need of appropriate brain SPECT templates for SPM comparisons.
    Morbelli S; Rodriguez G; Mignone A; Altrinetti V; Brugnolo A; Piccardo A; Pupi A; Koulibaly PM; Nobili F
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):89-98. PubMed ID: 18043545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: scintigraphic appearance of Tc-99m HMPAO brain spect.
    Lee BF; Liu CK; Tai CT; Chiu NT; Liu GC; Yu HS; Pai MC
    Kaohsiung J Med Sci; 2001 Aug; 17(8):394-400. PubMed ID: 11715838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: correlation with event related potentials.
    Gungor HA; Yildiz A; Aydin F; Gungor F; Boz A; Ozkaynak S
    J Neurol Sci; 2005 Jul; 234(1-2):47-53. PubMed ID: 15950243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
    O'Brien JT; Firbank MJ; Davison C; Barnett N; Bamford C; Donaldson C; Olsen K; Herholz K; Williams D; Lloyd J
    J Nucl Med; 2014 Dec; 55(12):1959-65. PubMed ID: 25453043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.